All Common P210 and P190 BCR-Abl Variants Can Be Targeted by RNA Interference

Leukemia - United Kingdom
doi 10.1038/sj.leu.2403603
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Related search

P210 and P190 BCR-ABL Fusion Transcripts Variants Frequencies Among Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Sudan

International Journal of Biomedical Research
2018English

Genomic Mechanisms of P210 BCR-ABL Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Development and Evaluation of Armored RNA-based Standards for Quantification of BCR-ABL1 P210/P190 Fusion Gene Transcripts

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2018English

Nilotinib Treatment in Mouse Models of P190 BCR/Abl Lymphoblastic Leukemia

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2007English

Papel Da P190 BCR-ABL Como Parâmetro De Recaída Na Leucemia Mielóide Crônica

Revista Brasileira de Hematologia e Hemoterapia
2008English

Arginine Butyrate Downregulates P210 BCR-Abl Expression and Induces Apoptosis in Chronic Myelogenous Leukemia Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1998English

IPO-trimethylation of Histone H3-Lysine9associated With P210 BCR-ABL Tyrosine Kinase of Chronic Myeloid Leukaemia

British Journal of Haematology
Hematology
2008English

Establishment and Phenotypic Characterization of Human U937 Cells With Inducible P210 BCR/ABL Expression Reveals Upregulation of CEACAM1 (CD66a)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

BCR-ABL Tyrosine Kinase

Science-Business eXchange
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy